Therapies, Investigational
"Therapies, Investigational" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Treatments which are undergoing clinical trials or for which there is insufficient evidence to determine their effects on health outcomes; coverage for such treatments is often denied by health insurers.
Descriptor ID |
D035703
|
MeSH Number(s) |
E02.931
|
Concept/Terms |
Therapies, Investigational- Therapies, Investigational
- Investigational Therapy
- Therapy, Investigational
- Investigational Treatments
- Investigational Treatment
- Treatment, Investigational
- Treatments, Investigational
- Experimental Therapies
- Experimental Therapy
- Therapies, Experimental
- Therapy, Experimental
- Investigational Therapies
|
Below are MeSH descriptors whose meaning is more general than "Therapies, Investigational".
Below are MeSH descriptors whose meaning is more specific than "Therapies, Investigational".
This graph shows the total number of publications written about "Therapies, Investigational" by people in this website by year, and whether "Therapies, Investigational" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2005 | 2 | 0 | 2 |
2008 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2013 | 2 | 1 | 3 |
2015 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2019 | 2 | 1 | 3 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Therapies, Investigational" by people in Profiles.
-
Ethical challenges of travel for experimental therapy in malignant brain tumor patients. J Neurosurg. 2023 06 02; 139(6):1802-1806.
-
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022. Ann Oncol. 2023 01; 34(1):48-60.
-
Unrealistic parental expectations for cure in poor-prognosis childhood cancer. Cancer. 2020 01 15; 126(2):416-424.
-
Presidential Forum. Ann Surg. 2019 10; 270(4):573-584.
-
Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance. Oncogene. 2019 08; 38(34):6159-6171.
-
Uterine Fibroids: Bridging Genomic Defects and Chronic Inflammation. Semin Reprod Med. 2017 11; 35(6):494-498.
-
Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers. Urol Oncol. 2016 12; 34(12):556-565.
-
New treatment models for compulsive disorders. Eur Neuropsychopharmacol. 2016 05; 26(5):877-84.
-
Peroral Endoscopic Myotomy for Achalasia. JAMA Surg. 2015 Aug; 150(8):806-7.
-
The biology and clinical development of MEK inhibitors for cancer. Drugs. 2014 Dec; 74(18):2111-28.